- Nachrichtendetail
-
18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Merck & Co | A0YD8Q | NYSE | 116,340 | 21.08.24 20:53:37 | +1,200 | +1,04% | 116,330 | 116,340 | 114,760 | 115,140 |
|
Ligand Pharmaceuticals | A1C9RN | NASDAQ | 106,400 | 21.08.24 20:51:15 | +2,060 | +1,97% | 106,170 | 106,430 | 105,000 | 104,340 |
